Evidence snapshot
A 16-amino-acid mitochondrial-derived peptide. Researchers study how this signal coordinates metabolism and exercise responses; naturally occurring MOTS-c and externally administered peptide are distinct research questions.
Why it stands out
The appealing idea is helping cells adapt when energy demand rises. That connects to endurance, aging muscle and insulin sensitivity, with the most direct intervention results so far coming from animal experiments.
How it may work
It appears to influence AMPK and cellular energy pathways, especially in skeletal muscle.
What studies found
A 2021 study found that exercise increased naturally occurring MOTS-c in humans. In the same research program, administering MOTS-c improved physical performance in mice of different ages. These are complementary findings, but only the mouse experiments tested added peptide for performance.
What the evidence means
A human exercise-associated rise supports biological relevance, not proof that injections improve human endurance. Trials of modified analogs such as CB4211 also should not be presented as trials of an identical retail MOTS-c preparation.
Safety and limitations
Human intervention data are limited, so long-term effects, interactions and reliable adverse-event rates remain uncertain. Changes in energy or appetite alone cannot establish safety or show what is happening to glucose regulation.
Current status
MOTS-c is not an FDA-approved drug. The 2027 WADA list names MOTS-c as an AMPK activator in class S4.4.1, prohibited at all times in tested sport.
Common questions
Is MOTS-c exercise in a vial? No. Mouse performance findings do not reproduce all the cardiovascular, muscular and psychological benefits of training. The research asks about one signaling pathway within a much larger response.
Personal accounts, not clinical results
Users in the linked thread describe unusually high energy; one also reports difficulty sleeping, and another says later attempts did not feel the same. These are subjective experiences, not a controlled demonstration of improved mitochondrial function.